<code id='0D69994A66'></code><style id='0D69994A66'></style>
    • <acronym id='0D69994A66'></acronym>
      <center id='0D69994A66'><center id='0D69994A66'><tfoot id='0D69994A66'></tfoot></center><abbr id='0D69994A66'><dir id='0D69994A66'><tfoot id='0D69994A66'></tfoot><noframes id='0D69994A66'>

    • <optgroup id='0D69994A66'><strike id='0D69994A66'><sup id='0D69994A66'></sup></strike><code id='0D69994A66'></code></optgroup>
        1. <b id='0D69994A66'><label id='0D69994A66'><select id='0D69994A66'><dt id='0D69994A66'><span id='0D69994A66'></span></dt></select></label></b><u id='0D69994A66'></u>
          <i id='0D69994A66'><strike id='0D69994A66'><tt id='0D69994A66'><pre id='0D69994A66'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:89996
          Sen. Bob Menendez (D-N.J.) Michael M. Santiago/Getty Images

          WASHINGTON — With mounting calls for embattled Sen. Bob Menendez to resign, the pharmaceutical industry could see one of its historical, and increasingly rare, Democratic allies ousted from Congress.

          The New Jersey senator is embroiled in another financial scandal after last week’s indictment over hundreds of thousands of dollars he and his wife allegedly accepted to influence military aid. The charges — which Menendez insists he will beat — come roughly seven years after he was accused of pressuring Medicare officials to resolve a dispute in favor of a lavish political donor. That case ended in a hung jury.

          advertisement

          But this time around, Capitol lawmakers and New Jersey Democrats including Sen. Cory Booker, a longtime legislation partner, are calling on Menendez to resign. The mounting pressure and looming court battle spell out a hazy future for one of the pharmaceutical industry’s biggest allies in the Democratic Party.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Surge in Apellis stock fueled by confidence in safety of its eye drug
          Surge in Apellis stock fueled by confidence in safety of its eye drug

          MollyFerguson/STATSharesofApellisPharmaceuticalsarerebounding,drivenbyagrowingbeliefamongsomeinvesto

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          Death toll from an explosion and collapse of a Paris building in June climbs to 3

          PARIS--Awomaninher70swhoworkedatadesignschoolhasdiedastheresultofanexplosionincentralParisamonthagot